M. Kamthania

Exploring the structural basis to develop efficient multi-epitope vaccines displaying interaction with HLA and TAP and TLR3 molecules to prevent NIPAH infection, a global threat to human health

This paper designs and in silico validates two multi-epitope vaccines against Nipah virus, incorporating CTL and HTL epitopes, B cell epitopes, and adjuvants, with potential for effective and specific immune response.

Computationally validated SARS-CoV-2 CTL and HTL Multi-Patch Vaccines designed by reverse epitomics approach, shows potential to cover large ethnically distributed human population worldwide

This paper designs and validates Multi-Patch Vaccines against SARS-CoV-2 using a reverse epitomics approach, showing potential to cover a large ethnically diverse human population.